Publication | Closed Access

Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease

Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryDual InhibitorsMedicineRational Drug DesignNeuropharmacologyBiological EvaluationDrug DevelopmentDrug Reposition-based DesignPharmacologyInhibitory ActivityTreatmentDrug Discovery